Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Eucrates Biomedical Acquisition Corp. (EUCR)

9.95   0 (0%) 08-08 01:32
Open: 9.95 Pre. Close: 9.95
High: 9.95 Low: 9.95
Volume: 0 Market Cap: 134(M)
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.97 - 10.02 10.02 - 10.06
Low: 9.81 - 9.88 9.88 - 9.93
Close: 9.86 - 9.96 9.96 - 10.04

Technical analysis

as of: 2022-08-05 4:21:50 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.62     One year: 13.57
Support: Support1: 9.91    Support2: 9.89
Resistance: Resistance1: 9.94    Resistance2: 11.62
Pivot: 9.94
Moving Average: MA(5): 9.94     MA(20): 9.93
MA(100): 9.89     MA(250): 9.82
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 100     %D(3): 97.2
RSI: RSI(14): 77
52-week: High: 10.73  Low: 9.64
Average Vol(K): 3-Month: 9 (K)  10-Days: 6 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ EUCR ] has closed below upper band by 15.7%. Bollinger Bands are 29.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 05 Aug 2022
Wolverine Asset Management LLC Sells 45165 Shares of Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) - Defense World

Thu, 04 Aug 2022
E.l.f. Beauty Shares Q1 2023 Results - Beauty Packaging Magazine

Thu, 17 Mar 2022
Woman Inserted A Glass Tumbler Inside Her Urethra, Forgot About It For Four Years - Daily Caller

Fri, 28 Jan 2022
e.l.f Cosmetics cements clean beauty status with new skin care range, Pure Skin - GlobalCosmeticsNews

Tue, 25 Jan 2022
E.l.f. Cosmetics Goes 100% Clean In Skin Care And Cosmetics - Beauty Packaging Magazine

Thu, 06 Jan 2022
Trump-Related SPACs DWAC and CFVI Jump on Truth Social Launch News - TheStreet

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Financial Services
Industry:  Shell Companies
Shares Out. 13 (M)
Shares Float 10 (M)
% Held by Insiders 19.4 (%)
% Held by Institutions 48.9 (%)
Shares Short 8 (K)
Shares Short P.Month 6 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.36
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -0.5
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 1.35
Price to Sales 0
Price to Cash Flow -266.73

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.